(Q43540730)

24 November 2017

title

Comparing long-term results of PASAT and SDMT scores in relation to neuropsychological testing in multiple sclerosis (English)

1 reference

24 November 2017

0 references

1 reference

Judith M Sonder

1

1 reference

24 November 2017

Jessica Burggraaff

2

1 reference

24 November 2017

Dirk L Knol

3

1 reference

24 November 2017

Chris H Polman

4

1 reference

24 November 2017

Bernard M J Uitdehaag

5

1 reference

24 November 2017

publication date

9 September 2013

1 reference

Multiple Sclerosis Journal

24 November 2017

published in

1 reference

24 November 2017

volume

20

1 reference

24 November 2017

issue

4

1 reference

24 November 2017

page(s)

481-488

1 reference

Cognitive impairment in multiple sclerosis

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458513501570

Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513501570

Cognitive impairment in early stages of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513501570

Neuropsychological measures in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513501570

Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513501570

Paced auditory serial-addition task: a measure of recovery from concussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513501570

Development of a multiple sclerosis functional composite as a clinical trial outcome measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513501570

A comprehensive review of the Paced Auditory Serial Addition Test (PASAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513501570

The Brief Repeatable Battery of Neuropsychological Tests for Multiple Sclerosis: a preliminary serial study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513501570

Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513501570

Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513501570

How to detect cognitive dysfunction at early stages of multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513501570

Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513501570

Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513501570

Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513501570

Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513501570

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513501570

Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513501570

Evaluating storage, retention, and retrieval in disordered memory and learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513501570

The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513501570

Applying linear mixed models to estimate reliability in clinical trial data with repeated measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513501570

Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513501570

Brief International Cognitive Assessment for MS (BICAMS): international standards for validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513501570

Who Invented the Delta Method?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513501570

21 January 2018

Identifiers

DOI

10.1177/1352458513501570

1 reference

24 November 2017

1 reference